Lv1
72 积分 2024-03-27 加入
Quantitative Thresholds on (18)F-DCFPyL PET for Determining Malignancy in Prostate Cancer with Pathologic Correlation
1天前
已关闭
Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM
2天前
已完结
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
2天前
已完结
Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block
2天前
已完结
Mavacamten and Aficamten in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Trials
2天前
已完结
Serial Strain-Based Echocardiographic Characterization of Early Left Heart Functional Changes During Short-Term Mavacamten Treatment in Obstructive Hypertrophic Cardiomyopathy
2天前
已完结
Real-world effectiveness, response patterns and clinical implementation of Mavacamten in obstructive hypertrophic cardiomyopathy: Insights from the SWISS-MAVA cohort
2天前
已完结
Real-world mavacamten: What SWISS-MAVA adds
2天前
已关闭
Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy
2天前
已完结
Impact of Mavacamten on Disease-Related Symptoms in Patients With Obstructive Hypertrophic Cardiomyopathy: HCMSQ Outcomes in EXPLORER-HCM
2天前
已完结
皖公网安备34019202002308
